Oncode Accelerator

Oncode Accelerator is a public-private partnership funded by the Dutch National Growth Fund (NGF), which aims to innovate and accelerate the preclinical development of new cancer therapies represented by our four workstreams: small molecules, biologics, cell and gene therapy and therapeutic vaccines. 

Together, we believe preclinical drug discovery and therapy development can be accelerated and de-risked using an innovative combination of well-defined patient cohorts, organoid models, and artificial intelligence platforms.

Oncode Accelerator is a collaboration between six coordinating partners: Leiden University, Leiden University Medical Center, the Netherlands Cancer Institute, Princess Máxima Center, UMC Utrecht and the Oncode Accelerator Foundation.

For more information about Oncode Accelerator you can visit their website.